PH
Pharming Group N.V.
PHGUF · OTC
$1.11 +0.00% (+$0.00)
Market Cap $835.2M
P/E Ratio 89.00x
Div. Yield -
ROE 3.47%
Bulios Fair Price
$1.19
7.7% upside
Current Price
$1.11
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PHGUF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
33 /100
Expensive EV/EBITDA 20.17x
P/S 2.28x
P/B 3.09x
Growth
68 /100
Growing Rev. growth 23.68%
FCF growth 34.73%
Book val. growth 10.62%
Profitability
46 /100
Moderate Net margin 2.56%
Op. margin 5.51%
FCF margin 7.04%
Quality
22 /100
Poor ROE 3.47%
ROA 2.01%
Asset turnover 0.78x
Debt
77 /100
Low Current ratio 3.01x
Int. coverage 0.02x
Net debt/EBITDA -1.14x
Stability
33 /100
Unstable Rev. volatility 6.93%
EPS volatility 154.56%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PHGUF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Fabrice Chouraqui
Employees
407
Headquarters
Leiden
Upcoming events
05 NOV
Earnings
Upcoming earnings report